The Broken Health Information Technology Innovation Pipeline: A Perspective from the NODE Health Consortium

Abstract

Background: The Network of Digital Evidence (NODE) was formed to further advance the field of health information technology (HIT) and evidence-based digital medicine at different healthcare institutions nationwide. As the NODE network reviewed the state of the field, it was noted that despite substantial financial and human capital investments, the processes and results of HIT innovation seem chaotic and subpar, especially in comparison to the more well-established drug and device industries. During the course of this white paper, we will explore the causes for this observed phenomenon as well as propose possible solutions to improve the state of HIT. Methods: We compared the entire process of discovery, proof of concept, Food and Drug Administration (FDA) review, and postmarket monitoring and distribution/implementation of HIT innovations to the equivalent processes for drugs and devices. Whereas drug and device innovations are subject to a standardized pipeline of production, HIT innovations are not held to equivalent standards. Conclusions: As a result, HIT lags behind the more mature drug and device industries in producing effective and reliable products. This leads to an inefficient use of already scarce healthcare resources. The authors believe that the HIT industry must adopt many of the mechanisms implemented by the drug and device industries as dictated by their innovation pipelines of discovery, proof of concept, FDA review, and postmarket monitoring and distribution/implementation. We propose an eight-point plan to fundamentally evolve the HIT lifecycle, including reforms for institutions such as neutral government agencies, new health system boards and management systems, modified incentive structures, improved relationships with financial investors and start-ups, patient engagement, and enhanced mechanisms to improve HIT adoption.

Addressing Disparities in Diabetes Management Through Novel Approaches to Encourage Technology Adoption and Use

“…The Network of Digital Evidence in Health (NODE Health) is applying evidence-based medicine rigor to address the current void in much digital health technology [95]. As a NODE Health consortium member, Sheon seeks to ensure [96] that overlooked SHI perspectives [97] are considered in assessment of digital health efficacy [98].…”

An Algorithm for Digital Medicine Testing: A NODE.Health Perspective Intended to Help Emerging Technology Companies and Healthcare Systems Navigate the Trial and Testing Period prior to Full-Scale Adoption

“…The traditional clinical testing paradigm does not neatly apply to digital medicine because many digital solutions do not require regulatory oversight [47]. Mobile applications that pose a risk to patient safety [48], make medical claims, or are seeking medical grade certification [49] invoke Food and Drug Administration (FDA) oversight.…”

“…In light of the many unique dimensions of digital health technology, Table 1 presents questions to consider when initiating or progressing with a phased trial process. These questions have been informed by the experience of NODE.Health in validating digital medicine technologies [47, 56–59], and by industry-sponsored surveys of digital health founders, health systems leaders, or technology developers [60, 61]; or other industry commentary [46, 62].…”

Why Aren't Our Digital Solutions Working for Everyone?

“…While the quantitative impact of these digital solutions is still yet to be determined [2], their potential for driving the next generation of care is indisputable [3,4]. But, as with other historical transformations, the solutions and associated shifts risk leaving certain groups or individuals behind [5,6].…”